I have been on AS followed by Behfar Ehdaie at MSK since 2020. PSA has been trending up with most recent being 6.1 Prior biopsy (2021) was G7 (3+4) with 3 positive cores out of ten. Two G6 and 1 G7 3+4 (with G4 in 2% of the core).
MRI in January 2023 showed two lesions with PIRADS 3 (no EPE, no SV involvement ). This was a slight change from initial MRI (2020) with two lesions, one with PIRADS 2 and the other with PIRADS 3.
New biopsy on April 17, 2023. Four of 10 cores with tumors. Two G6 cores (30% and 5% of the cores with carcinoma). Two G7 (4+3) cores. 40 and 45% of the cores with carcinoma. Both cores had 90% with G4. One of the G7 cores perineural invasion is identified.
I believe the change in Gleason score (from one core with 3+4 with low percent of G4 to two cores with 4+3 and a high percent of G4) moves me from grade group 2 (favorable intermediate risk) to grade group 3 (unfavorable intermediate risk).
Trying to schedule a call with Dr. Ehdaie in the next couple weeks to discuss the pathology and next steps.
What is the recommended treatment going forward? I am eager for opinions (Tall Allen especially) about optimal radiation approach (IMRT/SBRT/Brachy LDR or HDR, etc.) and whether ADT will be needed.